First Department of Cardiology, Athens School of Medicine, Hippokration Hospital, Athens, Greece.
Centre of Rheumatology, University College London, London, United Kingdom.
Curr Vasc Pharmacol. 2020;18(5):463-472. doi: 10.2174/1570161118666200130093432.
The vasculitides are a heterogeneous group of disorders, characterized by inflammatory cell infiltration and necrosis of blood vessels that cause vascular obstruction or aneurysm formation, affecting various organs such as lungs, kidneys, skin and joints. Cardiac involvement is commonly encountered in primary systemic vasculitis and it is associated with increased morbidity and mortality. Depending on the dominant pathophysiological mechanism, heart complications may manifest in different ways, including myocardial ischemia due to impaired micro- or macrovascular circulation, progressive heart failure following valvular heart disease and myocardial dysfunction, (sub) clinical myocarditis, pericarditis, pulmonary hypertension as well as arteritis of coronary vessels. Beyond cardioprotective regimens, aggressive immunosuppression reduces the inflammatory burden and modulates the progression of cardiovascular complications. Perioperative management of inflammation, when surgical treatment is indicated, improves surgical success rates and postoperative long-term prognosis. We aim to provide an overview of the pathogenetic, diagnostic and therapeutic principles of cardiovascular involvement disease in the various forms of systemic vasculitis.
血管炎是一组异质性疾病,其特征为炎症细胞浸润和血管坏死,导致血管阻塞或动脉瘤形成,影响肺部、肾脏、皮肤和关节等各种器官。原发性系统性血管炎常伴有心脏受累,并与发病率和死亡率增加相关。根据主要的病理生理机制,心脏并发症可能表现为不同的形式,包括由于微血管或大血管循环受损导致的心肌缺血、瓣膜性心脏病和心肌功能障碍后进行性心力衰竭、(亚)临床心肌炎、心包炎、肺动脉高压以及冠状动脉炎。除了心脏保护方案外,强化免疫抑制可减轻炎症负担并调节心血管并发症的进展。当需要手术治疗时,围手术期炎症管理可提高手术成功率和术后长期预后。我们旨在概述各种系统性血管炎中心血管受累疾病的发病机制、诊断和治疗原则。